These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12966627)

  • 21. Efficiency of potent gastric acid inhibition.
    Carballo F
    Drugs; 2005; 65 Suppl 1():105-11. PubMed ID: 16335864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastroesophageal reflux disease: current treatment approaches.
    Biddle W
    Director; 2003; 11(4):155-9. PubMed ID: 14608699
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of gastroesophageal reflux disease.
    Fass R; Bautista J; Janarthanan S
    Clin Cornerstone; 2003; 5(4):18-29; discussion 30-1. PubMed ID: 15101492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antacids. Indications and limitations.
    Ching CK; Lam SK
    Drugs; 1994 Feb; 47(2):305-17. PubMed ID: 7512903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.
    Thomson RM; Armstrong JG; Looke DF
    Chest; 2007 Apr; 131(4):1166-72. PubMed ID: 17426224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastro-oesophageal reflux disease.
    Moayyedi P; Talley NJ
    Lancet; 2006 Jun; 367(9528):2086-100. PubMed ID: 16798392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of gastro-oesophageal reflux disease in adults.
    Galmiche JP; Letessier E; Scarpignato C
    BMJ; 1998 Jun; 316(7146):1720-3. PubMed ID: 9614026
    [No Abstract]   [Full Text] [Related]  

  • 35. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.
    Jones R; Bytzer P
    Aliment Pharmacol Ther; 2001 Jun; 15(6):765-72. PubMed ID: 11380314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid reflux and gastro-oesophageal reflux disease.
    Watson AR; Bowling TE
    Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Gooszen HG; Besselink MG; Smout AJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2499; author reply 2499-500. PubMed ID: 14708218
    [No Abstract]   [Full Text] [Related]  

  • 39. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease.
    Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.
    Watson DI; Lally CJ
    World J Surg; 2009 Jan; 33(1):88-94. PubMed ID: 18949510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.